DTC is the exclusive U.S. supplier of the proprietary VibraSense®, a wireless, point-of-care device that evaluates both large and small nerve fiber function—delivering instant digital reports. This comprehensive assessment gives clinicians a full view of neurological health, enabling early detection of sensory loss and helping prevent irreversible nerve damage. VibraSense® makes it easy to proactively screen, diagnose, and manage neuropathy right at the point of care. 

Designed for precision and ease of use, this advanced device enables comprehensive sensory testing in a single handheld device.

• Vibration Perception – Assess large fiber function at 120 Hz

• Warm Sensation – Controlled heating up to 50 °C (122 °F)

• Cold Sensation – Cooling down to 15 °C (59 °F)

Ideal for screening peripheral neuropathy with digital reports that support findings and follow-up care.

Importance of Specificity

Diabetics that have lower-extremity amputations have lifespans that range between 40% mortality in 1-year, 65% mortality in 3-years, and 80% mortality in 5-years. Diabetic Neuropathy is a serious diabetes complication affecting as many as 50% of people who suffer from pain, and another 50% may be asymptomatic - who are at the highest risk of falls, ulcerations, and amputations. Nerve damage and poor circulation are the most common causes of diabetic foot problems. One of the most underdiagnosed and untreated parts of a comprehensive foot exam is checking the loss of protective sensation (LOPS) in the feet. The diabetic large nerve fiber dysfunction, as measured by vibration, predicts foot ulcerations, amputations, and mortality. 

(Painless) Diabetic large nerve fiber dysfunction as measured by vibration Predicts foot ulceration, amputation and mortality.

https://care.diabetesjournals.org/content/32/10/1896

The purpose of a comprehensive diabetic foot exam is to gather as much clinical data about the condition of a person's normal or abnormal condition in the feet of both large and small nerve fibers. A diabetic foot exam also checks people with diabetes for infection, injury, and bone abnormalities. However, over 99% of all medical providers use outdated and subjective tools (tuning fork, invented in 1711 or monofilaments, invented in 1938) to identify a progressive disease. Distal Symmetric Polyneuropathy (DSPN), a glove and stocking distribution, is the most common form of Diabetic Neuropathy (DN) and is recognized as the most troublesome complication of diabetes mellitus leading to the greatest morbidity and mortality, which accounts for the most amount of hospitalizations than all other diabetic complications combined and is responsible for up to 75% of non-traumatic amputations.

(Painful) Diabetic small fiber neuropathy can only be verified with thermal thresholds or skin biopsies.

Aaron Vinik, MD, Ph.D., Endocrinologist, Diabetic Neuropathies, February 5, 2018

The proper diagnosis of diabetic neuropathy should require tools to identify and measure the disorder quantitatively for the different abnormalities that occur to specific nerve fibers. Combining at least two different examinations (large and small fiber) will increase the sensitivity and specificity of detecting DPN. Currently, many medical providers are unaware of reimbursable tools that address both large fiber and small fiber neuropathy, both of which manifest in patients with diabetes. The VibraSense® is an FDA Registered multi-objective tool that identify both large and small nerve fibers in the upper and lower extremities.